Named on one round in the feed.
Since 2024-11-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Zenflow, Inc. Zenflow is a medical device company developing innovative therapies for the treatment of benign prostatic hyperplasia (BPH). | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $24M | 2024-11-18 | [ PART ] |